β³ Fetching live dividend data...
Home βΊ Calculator βΊ TBIO Dividend Calculator 2026
Telesis Bio, Inc. Β· OTC
Price: $0.05 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TBIO β $308765.64M in 10 years Β· $967,310,891.82/month
Telesis Bio, Inc., formerly known as Codex DNA, Inc. (and SGI-DNA, Inc. prior to that), is a San Diego, California-based synthetic biology company established in 2011. The company provides a comprehensive suite of instruments, reagents, and services for synthetic biology applications, catering primarily to pharmaceutical and academic laboratories worldwide. Its clientele also extends to government institutions, contract research organizations (CROs), and other synthetic biology enterprises. Among its core offerings is the BioXp system, a groundbreaking platform that empowers researchers to generate endpoint-ready synthetic DNA directly from digital sequences. Complementing this, the BioXp portal offers an intuitive online environment with guided workflows and design tools for constructing new DNA sequences and assembling them into desired vectors. For specific synthetic biology tasks, Telesis Bio supplies BioXp kits, which include essential building blocks and proprietary reagents like its well-known Gibson Assembly products. Additional solutions encompass cloud-based scripts and specialized benchtop reagents designed for post-BioXp system workflows. Through its Biofoundry Services, customers can commission and receive BioXp system-generated products, such as custom genes, clones, cell-free amplified DNA, and diverse variant libraries. The company also performs enzymatic DNA synthesis using short oligo ligation assembly techniques.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open TBIO position with:
Real after-tax yield depends on where you live and how you hold TBIO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 4000.00% | 3997.20% | $400,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 3400.00% | 3397.20% | $340,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 3200.00% | 3197.20% | $320,000 / yr |
| π¬π§ UK ISA | 0% | 4000.00% | 3997.20% | $400,000 / yr |
| π¬π§ UK Taxable | 8.75% | 3650.00% | 3647.20% | $365,000 / yr |
| π¨π¦ TFSA | 0% | 4000.00% | 3997.20% | $400,000 / yr |
| π¨π¦ CA Taxable | 25% | 3000.00% | 2997.20% | $300,000 / yr |
| π¦πΊ Super (pension) | 15% | 3400.00% | 3397.20% | $340,000 / yr |
| π¦πΊ AU Taxable | 30% | 2800.00% | 2797.20% | $280,000 / yr |
| π©πͺ DE Taxable | 26.375% | 2945.00% | 2942.20% | $294,500 / yr |
| π«π· FR Taxable | 30% | 2800.00% | 2797.20% | $280,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
TBIO pays quarterly β 4 times per year. Next ex-div: TBD.
How TBIO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TBIO sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2024-07-24 | 8,390 | β | β | ||
| A-Award | 2024-07-24 | 5,268 | $4.10 | $21.6K | ||
| A-Award | 2024-07-24 | 8,390 | β | β | ||
| A-Award | 2024-07-24 | 5,268 | $4.10 | $21.6K | ||
| A-Award | 2024-07-24 | 8,390 | β | β | ||
| A-Award | 2024-07-24 | 5,268 | $4.10 | $21.6K | ||
| A-Award | 2024-07-24 | 8,390 | β | β | ||
| A-Award | 2024-07-24 | 5,268 | $4.10 | $21.6K | ||
| A-Award | 2024-07-24 | 8,390 | β | β | ||
| A-Award | 2024-07-24 | 5,268 | $4.10 | $21.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TBIO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Telesis Bio, Inc. (TBIO) is currently trading at $0.05, 100% below its 52-week high. The current dividend yield is 4000.00% based on an annual payout of $2.00 per share.
Telesis Bio, Inc. (TBIO) is a healthcare stock currently trading at $0.05 with a dividend yield of 4000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β